sch 58261 Search Results


95
MedChemExpress 2a rs antagonist sch58261 medchemexpress
Pharmacological manipulation of PVT A 2A R regulates pain behaviors in mice. (A) Experimental timeline for cannula implantation, drug infusion (CGS21680 and <t>SCH58261),</t> and Von Frey and Hargreaves tests. (B) Diagram of injection cannula in the PVT region. (C, D) 50%PWTs (C) and PWLs (D) in mice treated with vehicle and CGS21680 (Vehicle, n = 11 mice; CGS21680, n = 11 mice). (E, F) 50%PWTs (E) and PWLs (F) in mice treated with vehicle and SCH58261. (Vehicle, n = 11 mice; 0.4 ng, n = 11 mice; 4 ng, n = 11 mice; 40 ng, n = 11 mice). * p < 0.05, ** p < 0.01. Data analyzed with unpaired t -test (C, D) , or one-way ANOVA followed by Tukey post-tests (E, F) . Error bars indicate SEM. PVT, paraventricular nucleus. D3V, Third ventricle. LV, Lateral ventricles.
2a Rs Antagonist Sch58261 Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/SCH+58261/pmc11693661-54-8-12
Average 95 stars, based on 1 article reviews
2a rs antagonist sch58261 medchemexpress - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
TargetMol sch58261
Pharmacological manipulation of PVT A 2A R regulates pain behaviors in mice. (A) Experimental timeline for cannula implantation, drug infusion (CGS21680 and <t>SCH58261),</t> and Von Frey and Hargreaves tests. (B) Diagram of injection cannula in the PVT region. (C, D) 50%PWTs (C) and PWLs (D) in mice treated with vehicle and CGS21680 (Vehicle, n = 11 mice; CGS21680, n = 11 mice). (E, F) 50%PWTs (E) and PWLs (F) in mice treated with vehicle and SCH58261. (Vehicle, n = 11 mice; 0.4 ng, n = 11 mice; 4 ng, n = 11 mice; 40 ng, n = 11 mice). * p < 0.05, ** p < 0.01. Data analyzed with unpaired t -test (C, D) , or one-way ANOVA followed by Tukey post-tests (E, F) . Error bars indicate SEM. PVT, paraventricular nucleus. D3V, Third ventricle. LV, Lateral ventricles.
Sch58261, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/SCH+58261/pm35753505-56-11-16
Average 93 stars, based on 1 article reviews
sch58261 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Tocris 2 furan 2 yl 7 phenethyl 7h pyrazolo
Pharmacological manipulation of PVT A 2A R regulates pain behaviors in mice. (A) Experimental timeline for cannula implantation, drug infusion (CGS21680 and <t>SCH58261),</t> and Von Frey and Hargreaves tests. (B) Diagram of injection cannula in the PVT region. (C, D) 50%PWTs (C) and PWLs (D) in mice treated with vehicle and CGS21680 (Vehicle, n = 11 mice; CGS21680, n = 11 mice). (E, F) 50%PWTs (E) and PWLs (F) in mice treated with vehicle and SCH58261. (Vehicle, n = 11 mice; 0.4 ng, n = 11 mice; 4 ng, n = 11 mice; 40 ng, n = 11 mice). * p < 0.05, ** p < 0.01. Data analyzed with unpaired t -test (C, D) , or one-way ANOVA followed by Tukey post-tests (E, F) . Error bars indicate SEM. PVT, paraventricular nucleus. D3V, Third ventricle. LV, Lateral ventricles.
2 Furan 2 Yl 7 Phenethyl 7h Pyrazolo, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/SCH+58261/10__1016_slash_j__jff__2024__106345-41-10-56
Average 95 stars, based on 1 article reviews
2 furan 2 yl 7 phenethyl 7h pyrazolo - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Tocris sch58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Sch58261, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/SCH+58261/pmc11071907-121-7-10
Average 95 stars, based on 1 article reviews
sch58261 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology sch58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Sch58261, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/SCH+58261/pm18522960-58-23-20
Average 90 stars, based on 1 article reviews
sch58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Schering-Plough corporation 3hsch58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
3hsch58261, supplied by Schering-Plough corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/sch+58261/10__1523_slash_eneuro__0385___18__2018-52-15-22
Average 90 stars, based on 1 article reviews
3hsch58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc 3 h-sch58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
3 H Sch58261, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/3h+5+amino+7++2+phenylethyl++2++2+furyl++pyrazolo+4+3+e++1+2+4+triazolo+1+5+c+pyrimidine+3h+sch+58261/pmc04915032-181-3-14
Average 90 stars, based on 1 article reviews
3 h-sch58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Potenza Therapeutics asp-8374
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Asp 8374, supplied by Potenza Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/sch+58261/pmc06833286-68-1-2
Average 90 stars, based on 1 article reviews
asp-8374 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Tokyo Chemical Industry sch 58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Sch 58261, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/sch+58261/pm34362890-265-0-5
Average 90 stars, based on 1 article reviews
sch 58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Verlag GmbH sch 58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Sch 58261, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/sch+58261/pm11487203-25-0-7
Average 90 stars, based on 1 article reviews
sch 58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EVJ Ltd sch-58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Sch 58261, supplied by EVJ Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/sch+58261/pm21496101-140-13-36
Average 90 stars, based on 1 article reviews
sch-58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cowen Inc sch 58261
Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist <t>SCH58261</t> (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test
Sch 58261, supplied by Cowen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sch+58261/sch+58261/10__1017_slash_s1461145707007845-101-31-16
Average 90 stars, based on 1 article reviews
sch 58261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Pharmacological manipulation of PVT A 2A R regulates pain behaviors in mice. (A) Experimental timeline for cannula implantation, drug infusion (CGS21680 and SCH58261), and Von Frey and Hargreaves tests. (B) Diagram of injection cannula in the PVT region. (C, D) 50%PWTs (C) and PWLs (D) in mice treated with vehicle and CGS21680 (Vehicle, n = 11 mice; CGS21680, n = 11 mice). (E, F) 50%PWTs (E) and PWLs (F) in mice treated with vehicle and SCH58261. (Vehicle, n = 11 mice; 0.4 ng, n = 11 mice; 4 ng, n = 11 mice; 40 ng, n = 11 mice). * p < 0.05, ** p < 0.01. Data analyzed with unpaired t -test (C, D) , or one-way ANOVA followed by Tukey post-tests (E, F) . Error bars indicate SEM. PVT, paraventricular nucleus. D3V, Third ventricle. LV, Lateral ventricles.

Journal: Frontiers in Pharmacology

Article Title: Microglial adenosine A 2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors

doi: 10.3389/fphar.2024.1467305

Figure Lengend Snippet: Pharmacological manipulation of PVT A 2A R regulates pain behaviors in mice. (A) Experimental timeline for cannula implantation, drug infusion (CGS21680 and SCH58261), and Von Frey and Hargreaves tests. (B) Diagram of injection cannula in the PVT region. (C, D) 50%PWTs (C) and PWLs (D) in mice treated with vehicle and CGS21680 (Vehicle, n = 11 mice; CGS21680, n = 11 mice). (E, F) 50%PWTs (E) and PWLs (F) in mice treated with vehicle and SCH58261. (Vehicle, n = 11 mice; 0.4 ng, n = 11 mice; 4 ng, n = 11 mice; 40 ng, n = 11 mice). * p < 0.05, ** p < 0.01. Data analyzed with unpaired t -test (C, D) , or one-way ANOVA followed by Tukey post-tests (E, F) . Error bars indicate SEM. PVT, paraventricular nucleus. D3V, Third ventricle. LV, Lateral ventricles.

Article Snippet: A 2A Rs agonist CGS21680 hydrochloride (MedChemExpress), A 2A Rs antagonist SCH58261 MedChemExpress) were firstly dissolved in DMSO, then diluted with 0.9% saline.

Techniques: Injection

PVT A 2A R antagonism alleviated CFA inflammatory pain. (A) Experimental timeline for cannula implantation, CFA or Saline (Sham) injection, drug infusion (SCH58261), and Von Frey and Hargreaves tests. (B, C) 50%PWTs and PWLs in Sham and CFA mice received vehicle or SCH58261 treatment at different time points following CFA injection. Von Frey test results show significantly increased mechanical pain threshold in 40 ng SCH58261-treated group compared to Vehicle group. (Sham Vehicle, n = 12 mice; Sham SCH, n = 11 mice; CFA_4h Vehicle, n = 15 mice; CFA_4h SCH, n = 16 mice; CFA_3d Vehicle, n = 10 mice; CFA_3d SCH, n = 8 mice). * p < 0.05, ** p < 0.01, *** p < 0.001. Data analyzed by (B, C) two-way ANOVA with Tukey post-tests. Error bars indicate SEM.

Journal: Frontiers in Pharmacology

Article Title: Microglial adenosine A 2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors

doi: 10.3389/fphar.2024.1467305

Figure Lengend Snippet: PVT A 2A R antagonism alleviated CFA inflammatory pain. (A) Experimental timeline for cannula implantation, CFA or Saline (Sham) injection, drug infusion (SCH58261), and Von Frey and Hargreaves tests. (B, C) 50%PWTs and PWLs in Sham and CFA mice received vehicle or SCH58261 treatment at different time points following CFA injection. Von Frey test results show significantly increased mechanical pain threshold in 40 ng SCH58261-treated group compared to Vehicle group. (Sham Vehicle, n = 12 mice; Sham SCH, n = 11 mice; CFA_4h Vehicle, n = 15 mice; CFA_4h SCH, n = 16 mice; CFA_3d Vehicle, n = 10 mice; CFA_3d SCH, n = 8 mice). * p < 0.05, ** p < 0.01, *** p < 0.001. Data analyzed by (B, C) two-way ANOVA with Tukey post-tests. Error bars indicate SEM.

Article Snippet: A 2A Rs agonist CGS21680 hydrochloride (MedChemExpress), A 2A Rs antagonist SCH58261 MedChemExpress) were firstly dissolved in DMSO, then diluted with 0.9% saline.

Techniques: Saline, Injection

Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist SCH58261 (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: Aβ 1-42 peptides blunt the adenosine A 2A receptor-mediated control of the interplay between P 2 X 7 and P 2 Y 1 receptors mediated calcium responses in astrocytes

doi: 10.1007/s00018-022-04492-y

Figure Lengend Snippet: Adenosine A2A receptors (A2AR) regulated astrocytic Ca2+ dynamics in control and Aβ1-42-exposed astrocytes. A2AR involvement in ATP-evoked Ca2+ response was evaluated using the selective antagonist SCH58261 (50 nM). A Representative time course of single-cell fluorescence recording of Ca2+ dynamics evoked by ATP (100 µM) in the presence or absence SCH58261 in astrocytes pre-exposed to Aβ1-42 (1 µM, for 1 h). In control conditions (no Aβ1-42 exposure), SCH58261 decreased the amplitude (B) of ATP-evoked Ca2+ response, but increased the duration of Ca2+ response (C). Astrocytes exposed to Aβ1-42 and further incubated with SCH58261 did not show differences in the amplitude of ATP-evoked Ca2+ response but displayed a significant decrease in the duration of ATP-evoked astrocytic Ca2+ response, indicating that A2AR are involved in alterations of astrocytic Ca2+ dynamics triggered by Aβ1-42 exposure. The amplitude and duration of Ca2+ response evoked by ATP were expressed in arbitrary units (a.u.) and seconds (s), respectively. Data are mean ± SEM of 3–12 independent experiments. *p < 0.05, **p < 0.01 as compared to control; ##p < 0.01 as compared Aβ1-42-treated astrocytes, Mann–Whitney test

Article Snippet: Western blot experiments Astrocytes were treated with SCH58261 (50 nM, Tocris) 30 min prior to challenge with Aβ 1-42 peptides (1 μM) for 24 h. Similarly P2 receptors antagonists MRS2179 (30 μM, Tocris), JNJ47965567 (1 μM, Tocris), pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid tetrasodium salt (PPADS, 10 μM, Abcam) and reactive blue 2 (RB-2, 2 μM, Sigma) were incubated for 24 h before analysis.

Techniques: Control, Fluorescence, Incubation, MANN-WHITNEY

Interaction between A2AR and P2 receptors (P2X7R and P2Y1R) in the regulation of Ca2+ responses in control and Aβ1-42-exposed astrocytes. Intracellular Ca2+ increases (Δ[Ca2+]i) evoked by the agonists of P2X7R, BzATP (100 µM, A) and of P2Y1R, MRS2365 (10 nM, B) in control and Aβ1-42 (1 µM, for 1 h)-treated astrocytes. Both agonists increased the Δ[Ca2+]i in control and in Aβ1-42-treated astrocytes, and these effects were attenuated by their respective antagonists JNJ7965567 (1 µM) and MRS2179 (30 µM). Although Δ[Ca2+]i evoked by BzATP was similar in control and Aβ1-42-exposed astrocytes, the Δ[Ca2+]i evoked by MRS2365 in Aβ1-42-treated astrocytes was significant lower than these observed in control astrocytes. The A2AR antagonist SCH58261 (50 nM) decreased the Δ[Ca2+]i evoked by either BzATP or MRS2365 in control astrocytes, but not in Aβ1-42-exposed astrocytes. Data are mean ± SEM of 4–10 independent experiments. *p < 0.05, ***p < 0.001, ****p < 0.0001 as compared to control, one-way ANOVA followed by Dunnett’s post hoc test; ##p < 0.01 as compared Aβ1-42-treated astrocytes, two-way ANOVA, post hoc Tukey’s test

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: Aβ 1-42 peptides blunt the adenosine A 2A receptor-mediated control of the interplay between P 2 X 7 and P 2 Y 1 receptors mediated calcium responses in astrocytes

doi: 10.1007/s00018-022-04492-y

Figure Lengend Snippet: Interaction between A2AR and P2 receptors (P2X7R and P2Y1R) in the regulation of Ca2+ responses in control and Aβ1-42-exposed astrocytes. Intracellular Ca2+ increases (Δ[Ca2+]i) evoked by the agonists of P2X7R, BzATP (100 µM, A) and of P2Y1R, MRS2365 (10 nM, B) in control and Aβ1-42 (1 µM, for 1 h)-treated astrocytes. Both agonists increased the Δ[Ca2+]i in control and in Aβ1-42-treated astrocytes, and these effects were attenuated by their respective antagonists JNJ7965567 (1 µM) and MRS2179 (30 µM). Although Δ[Ca2+]i evoked by BzATP was similar in control and Aβ1-42-exposed astrocytes, the Δ[Ca2+]i evoked by MRS2365 in Aβ1-42-treated astrocytes was significant lower than these observed in control astrocytes. The A2AR antagonist SCH58261 (50 nM) decreased the Δ[Ca2+]i evoked by either BzATP or MRS2365 in control astrocytes, but not in Aβ1-42-exposed astrocytes. Data are mean ± SEM of 4–10 independent experiments. *p < 0.05, ***p < 0.001, ****p < 0.0001 as compared to control, one-way ANOVA followed by Dunnett’s post hoc test; ##p < 0.01 as compared Aβ1-42-treated astrocytes, two-way ANOVA, post hoc Tukey’s test

Article Snippet: Western blot experiments Astrocytes were treated with SCH58261 (50 nM, Tocris) 30 min prior to challenge with Aβ 1-42 peptides (1 μM) for 24 h. Similarly P2 receptors antagonists MRS2179 (30 μM, Tocris), JNJ47965567 (1 μM, Tocris), pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid tetrasodium salt (PPADS, 10 μM, Abcam) and reactive blue 2 (RB-2, 2 μM, Sigma) were incubated for 24 h before analysis.

Techniques: Control

Impact of Aβ1-42 on the densities of P2X7R and P2Y1R in astrocytes: regulation by A2AR. The densities of P2X7R (A) and P2Y1R (B) were evaluated in astrocytes control (CTRL) and in astrocytes exposed to Aβ1-42. (1 µM, for 24 h). Aβ1-42 did not affect P2X7R levels, but significantly increased P2Y1R levels and this increase was prevented by the selective A2AR antagonist SCH58261 (50 nM, co-incubated with Aβ1-42 for 24 h). Graph bars represent the ratio of immunoreactivities between A P2X7R and β-actin (used as a loading protein control) or between B P2Y1R and β-actin and were expressed as a percentage of values of control cells. Representative immunoblotting of P2X7R (75 kDa), P2Y1R (45 kDa) and β-actin (42 kDa) are also shown. Data are mean ± S.E.M. of 10–12 independent experiments. *p < 0.05 as compared to control (100%), one sample t test

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: Aβ 1-42 peptides blunt the adenosine A 2A receptor-mediated control of the interplay between P 2 X 7 and P 2 Y 1 receptors mediated calcium responses in astrocytes

doi: 10.1007/s00018-022-04492-y

Figure Lengend Snippet: Impact of Aβ1-42 on the densities of P2X7R and P2Y1R in astrocytes: regulation by A2AR. The densities of P2X7R (A) and P2Y1R (B) were evaluated in astrocytes control (CTRL) and in astrocytes exposed to Aβ1-42. (1 µM, for 24 h). Aβ1-42 did not affect P2X7R levels, but significantly increased P2Y1R levels and this increase was prevented by the selective A2AR antagonist SCH58261 (50 nM, co-incubated with Aβ1-42 for 24 h). Graph bars represent the ratio of immunoreactivities between A P2X7R and β-actin (used as a loading protein control) or between B P2Y1R and β-actin and were expressed as a percentage of values of control cells. Representative immunoblotting of P2X7R (75 kDa), P2Y1R (45 kDa) and β-actin (42 kDa) are also shown. Data are mean ± S.E.M. of 10–12 independent experiments. *p < 0.05 as compared to control (100%), one sample t test

Article Snippet: Western blot experiments Astrocytes were treated with SCH58261 (50 nM, Tocris) 30 min prior to challenge with Aβ 1-42 peptides (1 μM) for 24 h. Similarly P2 receptors antagonists MRS2179 (30 μM, Tocris), JNJ47965567 (1 μM, Tocris), pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid tetrasodium salt (PPADS, 10 μM, Abcam) and reactive blue 2 (RB-2, 2 μM, Sigma) were incubated for 24 h before analysis.

Techniques: Control, Incubation, Western Blot